Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Lymphoma

  Free Subscription


24.08.2026

1 Am J Surg Pathol
2 Blood
2 Bone Marrow Transplant
4 Br J Haematol
1 Eur J Haematol
10 Haematologica
1 Leuk Lymphoma
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. GRAND DG, Cloutier JM, Palmer-DeClara SR, Karrs JX, et al
    TRBC1 Immunohistochemistry Utilization in Formalin-fixed Paraffin-embedded Tissue as an Adjunct to T-cell Clonality Testing in the Assessment of Cutaneous Lymphoproliferative Disorders.
    Am J Surg Pathol. 2026;50:1007-1014.
    PubMed         Abstract available


    Blood


  2. Casulo C, Dixon JG, Le-Rademacher J, et al; FLASH (Follicular Lymphoma Analysis of Surrogacy Hypothesis) Group. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood. 2022;139(1
    Blood. 2026;148:1067.
    PubMed        

  3. REJESKI K, Banerjee R, Hill JA
    How I prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies.
    Blood. 2026;148:927-938.
    PubMed         Abstract available


    Bone Marrow Transplant

  4. LIU J, Wang C, Min H, Chen J, et al
    A real-world, multi-center, retrospective study of autologous hematopoietic stem cell transplantation in 33 patients with HIV-associated lymphoma in China (CALL-006 Study).
    Bone Marrow Transplant. 2026 Aug 19. doi: 10.1038/s41409-026-02973.
    PubMed        

  5. IACOBONI G, Barba P, Khvedelidze I, Ngoya M, et al
    Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an international survey on behalf of the EBMT lymphoma working party.
    Bone Marrow Transplant. 2026 Aug 18. doi: 10.1038/s41409-026-03013.
    PubMed        


    Br J Haematol

  6. CEPPI F, Abla O, Abramov D, Csomor J, et al
    Characteristics and outcome of T-cell/histiocyte-rich large B-cell lymphoma in childhood and adolescence: An international retrospective analysis.
    Br J Haematol. 2026 Aug 20. doi: 10.1111/bjh.70774.
    PubMed        

  7. DICKINSON MJ, Berkahn L, Trotman J, Butler J, et al
    Pembrolizumab as first therapy for elderly or comorbid patients with classical Hodgkin lymphoma: Results of the phase 2 PLIMATH trial.
    Br J Haematol. 2026 Aug 19. doi: 10.1111/bjh.70777.
    PubMed        

  8. KIM WS, Kim SJ, Jo JC, Yoon SE, et al
    Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.
    Br J Haematol. 2026 Aug 18. doi: 10.1111/bjh.70742.
    PubMed         Abstract available

  9. TOWNSEND W, Ghosh N, Hutchings M, Dickinson M, et al
    Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Phase 1b dose-escalation study.
    Br J Haematol. 2026 Aug 17. doi: 10.1111/bjh.70741.
    PubMed         Abstract available


    Eur J Haematol

  10. YAO Y, Sungur S, Wellard C, Chung E, et al
    Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R-CHOP: A Lymphoma Registry Study.
    Eur J Haematol. 2026 Aug 18. doi: 10.1111/ejh.70295.
    PubMed         Abstract available


    Haematologica

  11. FRIDBERG G, Amit O, Sherf Y, Perry C, et al
    ICANS mitigation in high-risk elderly patients treated with CD28 co-stimulatory anti-CD19 CAR-T cells using a standardization protocol: a pilot study.
    Haematologica. 2026;111:2622-2631.
    PubMed         Abstract available

  12. LIA K, Jorgensen RRK, Wikman P, Wold BL, et al
    Erratum to: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma".
    Haematologica. 2026;111:2870-2872.
    PubMed        

  13. PELCOVITS A, Olszewski AJ
    The problem with "unfit": lessons from modern therapy for older patients with Hodgkin lymphoma.
    Haematologica. 2026 Jul 30. doi: 10.3324/haematol.2026.301510.
    PubMed         Abstract available

  14. ROCHA V, Mooyaart JE, Ram R, Clesham K, et al
    Improved progression free survival after axicabtagene ciloleucel compared to tisagenlecleucel, in patients aged >70 years with large B-cell lymphoma.
    Haematologica. 2026 Aug 13. doi: 10.3324/haematol.2026.300508.
    PubMed         Abstract available

  15. HUANG M, Shopsowitz K, Bahmanyar M, Hamadeh Z, et al
    Co-occurring systemic mastocytosis and T-lymphoblastic lymphoma driven by a novel cryptic JAKMIP2::PDGFRB rearrangement.
    Haematologica. 2026 Aug 13. doi: 10.3324/haematol.2026.301041.
    PubMed         Abstract available

  16. RENAUD L, Chaillol I, Galtier J, Bommier C, et al
    Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin's lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial.
    Haematologica. 2026 Aug 13. doi: 10.3324/haematol.2026.301194.
    PubMed         Abstract available

  17. GOULD P, Coskey D, Ma X, Wang S, et al
    Post-treatment circulating tumor DNA in large B-cell lymphoma with an immunoglobulin-based assay: real-world outcomes.
    Haematologica. 2026 Aug 13. doi: 10.3324/haematol.2026.300901.
    PubMed         Abstract available

  18. HAWKES EA, Chung E, Bishton MJ, Bolanos N, et al
    Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.
    Haematologica. 2026 Aug 13. doi: 10.3324/haematol.2026.301008.
    PubMed         Abstract available

  19. SMITH EJ, Binkley MS
    Navigating murky waters: risk scores for nodular lymphocyte-predominant Hodgkin lymphoma.
    Haematologica. 2026 Aug 20. doi: 10.3324/haematol.2026.301632.
    PubMed         Abstract available

  20. GROMMES C, Schaff LR
    Making remissions last: the promise of maintenance in primary central nervous system lymphoma.
    Haematologica. 2026 Aug 20. doi: 10.3324/haematol.2026.301604.
    PubMed         Abstract available


    Leuk Lymphoma

  21. TROTIER D, Liu M, Augustine A, Vembu K, et al
    Palliative care and hospice utilization in patients with relapsed or refractory diffuse large B-cell lymphoma in the era of CART and novel immunotherapies.
    Leuk Lymphoma. 2026 Aug 16:1-9. doi: 10.1080/10428194.2026.2715204.
    PubMed         Abstract available


    PLoS One


  22. Correction: Risk of hepatitis B virus reactivation in the treatment of HBsAg and HBV DNA double-negative lymphoma patients.
    PLoS One. 2026;21:e0356789.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum